Clinical Trials Browser

Phase 2 × Adenoma, Islet Cell × Bortezomib × Clear all

NCT00017199 2013-01-31

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Phase 2 Completed

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma